18 October 2021
Top hires for VC & PE portfolio companies Q3-2021
Search Highlights
Recent top global hires for Venture Capital and Private Equity backed companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.
This quarter’s successful placements include:
| Function | Focus area | Location |
|---|---|---|
| CEO | Oncology | US |
| Chief Operating Officer | A.I. for drug discovery | UK |
| Chief Medical Officer | Autoimmune disorders | UK |
| Chief Scientific Officer | Metabolomics technology | US |
| Chief Business Officer | Immunotherapies | Switzerland |
| Chief Technology Officer | Life science tools | US |
| SVP Pharma Strategy & Growth | Digital health | UK |
| VP R&D | CNS gene therapies | US |
| VP Clinical Development | Oncology & vaccines | UK |
| VP Chemistry | RNA therapeutics | US |
| Head of Sales & Marketing | Medical devices | Germany |
| Head of Preclinical | Immune-oncology | UK |
| Country Manager UK | DNA-based diagnostics | Sweden |
| Scientific Affairs Director | Contract manufacturing | France |
| Board Director | Oncology and autoimmune diseases | France |
| Partner | Life sciences venture capital | Netherlands |
Newly opened projects include:
| Function | Focus area | Location |
|---|---|---|
| Chief Financial Officer | COVID-19 therapeutics | UK |
| Chief Commercial Officer | Digital pathology | France |
| Chief Medical Officer | Oncology and rare diseases | UK |
| Chief Operating Officer | Digital (mental) health | Germany |
| Country CFO | Veterinary services | Norway |
| VP Clinical Development | CNS gene therapy | US |
| VP CMC | Precision biotherapeutics | Singapore |
| Head of Commercial | Digital therapeutics | US |
| Head of Regulatory Affairs | Gene therapy | US |
| Global Director Medical & Scientific Affairs | Wound care | UK |
| 2x Board Director | Autoimmunology disorders | Denmark |
| Chair | Drug discovery services | UK |
| Partner | Life science venture capital | Canada |